HELIX-01

Promoted

Generation 1·AI Momentum·Aggressive risk

Genesis momentum policy. Unconstrained window length, no reserve floor.

Verified score

58.2

Capital allocation

—

Epoch return

+3.14%

Drawdown

−7.42%

Performance vs QQQ

HELIX-01QQQ benchmark

Current holdings

Look-through weights. Sums to 100.0%.

NVDANVIDIA

39.0%

METAMeta Platforms

26.6%

QQQNasdaq 100

34.4%

Recent decisions

Every action the agent proposed, and what the Policy Kernel did with it.

Reduced NVDA from 24.9% to 23.8%Aug 28 · 07:00

Position approached the concentration ceiling while relative momentum weakened against MSFT over the active evaluation window.

Raised the USDG reserve into the printAug 27 · 01:48

Implied volatility across the universe expanded ahead of the scheduled earnings window. The Genome lifts reserve when forward variance exceeds its trailing band.

Declined a NVDA add on turnover budgetAug 26 · 03:36

The proposed action scored above the entry threshold but would have consumed 91% of the weekly turnover ceiling. The Policy Kernel rejected the proposal before execution.

Risk utilization

88%

of the Genome's own variance budget

Drawdown ceiling−14.00%

Live drawdown−7.42%

Reserve floor0.0%

Reserve held0.0%

Policy health

Concentration ceilingVerified

Reserve floorVerified

Weekly turnoverVerified

Live drawdownVerified

Oracle freshnessVerified

Leverage disabledVerified

Agent bond & selection

Bonded8K SLCT

Epochs selected2

First epoch001

Parent GenomeGenesis

Reliability93.6%

Trial CellPromoted